ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1319

Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage

Abdurrahman Tufan1, Berkan Armagan2, Erdal Bodakci3, Timucin Kasifoglu4, Hasan Satis5, Nuh Atas1, Alper Sari2, Hakan Babaoglu1, Gozde Yardımcı2, Reyhan Salman1, Levent Kilic2, Nazife Sule Yasar Bilge3 and Mehmet Akif Ozturk1, 1Internal Medicine-Rheumatology, Gazi University Faculty of Medicine, Ankara, Turkey, 2Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 3Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, 4Department of Internal Medicine, Division of Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, 5Rheumatology, Gazi University, Faculty of Medicine, Ankara, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Autoinflammatory Disease and familial Mediterranean fever

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Familial Mediterranean Fever (FMF) is the most frequent auto-inflammatory disease caused by MEFV gene mutations. Although FMF is characterized by intermittent inflammatory attacks some patients exert chronic persistent inflammation that can result in damage of multiple organs. Available reports investigated only specific components of damage such as amyloidosis. All possible organ targets of damage have not been entirely evaluated before.

To investigate all components of FMF related damage and associated factors with damage.

Methods: All patients recruited from FMF in Central Anatolia (FiCA) cohort, currently comprising 664 adult subjects (mean age 36±12.1, 63.5% female). All patients fulfilled Tel Hashomer criteria and all were using colchicine for at least 1 year. Demographic data, FMF disease and mutation (if available) characteristics and treatment features were recorded. FMF related damage was evaluated with recently validated auto-inflammatory disease damage index (ADDI). Association between damage and demographic, disease and treatment characteristics were analyzed.

Results: Proportions of FMF manifestations were fever 81,2%, peritonitis 90%, pleuritis 48.8%, arthritis 54.4% and skin rash 29%. Dominant attack types were fever in 7.1%, serositis in 62.7%, musculoskeletal in 16.7% and all attacks were common in rest of patients. MEFV mutations were available in 536 subjects and 77.6% of subjects harboring M694V mutation (28.8% homozygous for M694V). Among all 59.5% patients were well responded to colchicine and 9.2% were non-responders. Median ADDI score was 1 (min 0 max 11). Most common FMF related damages were observed in musculoskeletal, reproductive and kidney domains. Chronic musculoskeletal pain was present in 52.4%, joint deformity in 2.7%, infertility in 11.2%, amenorrhea in 7.1%, proteinuria in 7.8%, amyloidosis in 6.8% and severe renal failure in 4.1%. Age, M694V homozygous mutation, presence of persistent inflammation, dominant musculoskeletal attacks and colchicine nonresponse were found to be the independent predictors of damage.

Conclusion: M694V homozygous mutation, persistent inflammation, colchicine non-response and musculoskeletal dominant attacks are predictors of damage and effective therapeutic interventions must be undertaken to prevent from damage in these patients.


Disclosure: A. Tufan, None; B. Armagan, None; E. Bodakci, None; T. Kasifoglu, None; H. Satis, None; N. Atas, None; A. Sari, None; H. Babaoglu, None; G. Yardımcı, None; R. Salman, None; L. Kilic, None; N. S. Yasar Bilge, None; M. A. Ozturk, None.

To cite this abstract in AMA style:

Tufan A, Armagan B, Bodakci E, Kasifoglu T, Satis H, Atas N, Sari A, Babaoglu H, Yardımcı G, Salman R, Kilic L, Yasar Bilge NS, Ozturk MA. Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/familial-mediterranean-fever-related-damage-assessed-by-auto-inflammatory-disease-damage-index-addi-and-associated-factors-with-damage/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/familial-mediterranean-fever-related-damage-assessed-by-auto-inflammatory-disease-damage-index-addi-and-associated-factors-with-damage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology